Syon Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62M Buy
28,524
+1,974
+7% +$173K 0.11% 128
2026
Q1
$2.26M Sell
26,550
-2,544
-9% -$227K 0.11% 132
2025
Q4
$2.3M Buy
29,094
+18,015
+163% +$1.41M 0.11% 135
2025
Q3
$886K Sell
11,079
-3,692
-25% -$315K 0.05% 299
2025
Q2
$1.34M Buy
14,771
+4,231
+40% +$386K 0.09% 162
2025
Q1
$988K Buy
10,540
+2,650
+34% +$237K 0.08% 190
2024
Q4
$717K Sell
7,890
-646
-8% -$61.6K 0.06% 207
2024
Q3
$886K Buy
8,536
+322
+4% +$32.8K 0.08% 181
2024
Q2
$797K Buy
8,214
+140
+2% +$12.9K 0.07% 188
2024
Q1
$727K Buy
8,074
+680
+9% +$57.6K 0.07% 208
2023
Q4
$589K Buy
7,394
+3,501
+90% +$263K 0.06% 224
2023
Q3
$277K Buy
+3,893
New +$291K 0.03% 288

Other funds holding CL

Syon Capital's CL Position: Q2 2026 in Review

Syon Capital increased its Colgate-Palmolive (CL) stake by 7.4% in Q2 2026, buying an estimated $173K and bringing the position to 28,524 shares worth $2.62M. The position accounts for 0.11% of the portfolio, ranked #128.

Syon Capital first reported a position in CL in Q3 2023 and has held it in 12 quarters since. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Syon Capital held 28,524 shares of Colgate-Palmolive worth $2.62M as of Q2 2026.
  • Syon Capital bought 1,974 Colgate-Palmolive shares in Q2 2026, an estimated $173K.
  • Colgate-Palmolive made up 0.11% of Syon Capital's portfolio in Q2 2026, its #128 holding.
  • Syon Capital first reported a position in Colgate-Palmolive in Q3 2023 and has held it in 12 quarters since.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.